Involvement of activator protein-1 and nuclear factor-κB transcription factors in the control of the DT-diaphorase expression induced by mitomycin C treatment

Molecular Pharmacology

Volumn 51, Issue 3, 1997, Pages 422-430

  Yao, Kang Shen ^a   Hageboutros, Alexandre ^b   Ford, Patricia ^b   O'Dwyer, Peter J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOMYCIN C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TRANSCRIPTION FACTOR AP 1;

ARTICLE; BASE PAIRING; CANCER CELL CULTURE; CONTROLLED STUDY; DNA FLANKING REGION; DRUG DETOXIFICATION; DRUG MECHANISM; ELECTROPHORETIC MOBILITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; REPORTER GENE; TATA BOX; TRANSCRIPTION REGULATION;

DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION; HUMANS; MITOMYCIN; NAD(P)H DEHYDROGENASE (QUINONE); NF-KAPPA B; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030996269     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Crooke, S. T. and W. T. Bradner. Mitomycin C: a review. Cancer Treat. Rev. 3:121-139 (1976).
2. Ross, D., D. Siegel, H. Beach, A. S. Prakash, R. T. Mulcahy, and N. W. Gibson. DT-diaphorase in activation and detoxification of quinones. Cancer Metab. Rev. 12:83-101 (1993).
3. Tomasz, M., R. Lipman, D. Chowdary, J. Powlak, G. L. Verdine, and K. Nakanishi. Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science (Washington D. C.) 235:1204-1208 (1987).
4. Prakash, A. S., H. Beall, D. Ross, and N. W. Gibson. Sequence-selective alkylation and cross-linking induced by mitomycin C upon activation by DT-diaphorase. Biochemistry 32:5518-5525 (1993).
5. Doroshow, J. H. Reductive activation of mitomycin C: a delicate balance. J. Natl. Cancer Inst. 84:1138-1139 (1992).
6. Bachur, N. R., S. L. Gordon, M. V. Gee, and H. Kon. NADPH-cytochrome P450 reductase activation of quinone anticancer agents to free radicals. Proc. Natl. Acad. Sci. USA 76:954-957 (1979).
7. Keyes, S. R., P. M. Fracasso, D. C. Heimbrook, S. Rockwell, S. G. Sligar, A. C. Sartorelli. Role of NADPH:cytokine C reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Res. 44:5638-5643 (1984).
8. Pan, S. S., P. A. Andrews, C. J. Glover, N. R. Bachur. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytokine P450 reductase and xanthine oxidase. J. Biol. Chem. 257:959-966 (1984).
9. Rockwell, S., S. R. Keyes, and A. C. Saltorelli. Modulation of the cytotoxicity of mitomycin C to EMT6 mouse mammary tumor cells by dicoumarol in vitro. Cancer Res. 48:5471-5474 (1988).
10. Workman, P., M. I. Walton, G. Powis, J. J. Schlager. DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs? Br. J. Cancer 60:800-802 (1989).
11. Gustafson, D. L., and C. H. Pritsos. Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors. J. Natl. Cancer Inst. 84:1180-1185 (1992).
12. Siegel, D., N. W. Gibson, P. C. Preusch, and D. Ross. Metabolism of mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res. 50:7483-7489 (1990).
13. Begleiter, A., E. Robothanen, and M. K. Leith. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia. Mol. Pharmacol. 41:677-682 (1992).
14. Beall, H. D., R. T. Mulcahy, D. Siegel, R. D. Traver, N. W. Gibson, and D. Ross. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases. Cancer Res. 54:3196-3201 (1994).
15. Schlager, J. J., and G. Powis. Cytosolic NAD(P)H:quinone acceptor oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int. J. Cancer 45:403-409 (1990).
16. Holbrook, N. J., and A. J. Fornace Jr. Response to adversity: molecular control of gene activation following genotoxic stress. New Biol. 3:825-833 (1991).
17. Angel, P. E., and P. A. Herrlich, eds. The FOS and JUN Families of Transcription Factors. CRC Press, Boca Raton (1994).
18. Li, Y., and A. K. Jaiswal. Regulation of human NAD(P)H:quinone oxidoreductase gene: role of AP-1 binding site contained within human antioxidant response element. J. Biol. Chem. 267:15097-15104 (1992).
19. Yao, K.-S., S. Xanthoudakis, T. Curran, and P. J. O'Dwyer. Activation of AP-1 and of a nuclear redox factor ref-1 in the response of HT29 colon cancer cells to hypoxia. Mol. Cell Biol. 14:5997-6003 (1994).
20. Yao, K.-S., and P. J. O'Dwyer. Involvement of NF-κB in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol. 49:275-282 (1995).
21. Benson, A. M., M. J. Hunkeler, and P. Talalay. Possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA 77:5216-5220 (1980).
22. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159 (1987).
23. Cleveland, D. W., M. A. Lopata, R. J. MacDonald, W. J. Rutter, and M. W. Kirschner. Number and evolutionary conservation of α and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes. Cell 20:95-105 (1980).
24. Celano, P., C. Berchtold, and R. A. Casero Jr. A simplification of the nuclear run off transcription assay. Biotechniques 7:942-944 (1989).
25. Greenberg, M. E. Identification of newly transcribed RNA, in Current Protocols in Molecular Biology (F. M. Ausubel, R. Brent, R. E. Kingston, D. O. Moore, J. A. Smith, J. G. Seidman, and K. Strahl, eds.). John Wiley & Sons, New York, 4.10.1-4.10.8 (1988).
26. Angel, P., E. A. Allegretto, S. T. Okino, K. Hattori, W. J. Boyle, T. Hunter, and M. Karin. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature (Lond.) 332:166-171 (1988).
27. Curran, T., P. McConnell, F. Van-Straten, and I. M. Verma. Structure of the FBJ murine osteosarcoma virus genome: molecular cloning of its associated helper cells. Mol. Cell Biol. 3:914-921 (1983).
28. 3H locus in Burkitt lymphoma. Cell 34:779-787 (1983).
29. Dignam, J. P., R. M. Lebowitz, and R. G. Roeder. Accurate transcription initiation by RNA polymerase II in a soluble extract from mammalian nuclei. Nucleic Acids Res. 11:1475-1489 (1983).
30. Benjamin, I. J., B. Kroger, and R. S. Williams. Activation of the heat shock transcription factor by hypoxia in mammalian cells. Proc. Natl. Acad. Sci. USA 87:6263-6267 (1990).
31. Sambrook, J., E. F. Fritsch, and T. Maniatis. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
32. 1) gene structure and induction by dioxin. Biochemistry 30:10647-10653 (1991).
33. Baeuerle, P. A. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072:63-80 (1991).
34. Keyes, S. R., S. Rockwell, and A. C. Sartorelli. Enhancement of mitomycin cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. Cancer Res. 45:213-216 (1985).
35. Malkinson, A. M., D. Siegel, G. L. Forrest, A. F. Gazdar, H. K. Oie, D. C. Chan, P. A. Bunn, M. Mabry, D. J. Dykes, S. D. Harrison, and D. Ross. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin C. Cancer Res. 52:4752-4757 (1992).
36. Marshall, R. S., M. C. Paterson, and A. M. Rauth. DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strands derived from members of a cancer-prone family. Carcinogenesis (Lond.) 12:1175-1180 (1991).
37. Plumb, J. A., M. Gerrisen, and P. Workman. DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone E09. Br. J. Cancer 70:1136-1143 (1994).
38. Riley, R. J., and P. Workman. DT-diaphorase and cancer chemotherapy. Biochim. Pharmacol. 43:1657-1669 (1992).
39. Gustafson, D. L., and C. A. Pritsos. Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors. J. Natl. Cancer Inst. 84:1180-1185 (1992).
40. Gustafson, D. L., and C. A. Pritsos. Kinetics and mechanism of mitomycin C bioactivation by xanthine dehydrogenase under aerobic and hypoxic conditions. Cancer Res. 53:5470-5474 (1993).
41. Devary, Y., R. A. Gottlieb, L. F. Lau, and M. Karin. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell Biol. 11:2804-2811 (1991).
42. Yao, K.-S., S. W. Johnson, A. K. Godwin, R. F. Ozols, P. J. O'Dwyer, and T. C. Hamilton. Evidence for altered regulation of γ-glutamylcysteine synthetase gene expression among cisplatin-sensitive and -resistant human ovarian cancer cell lines. Cancer Res. 55:4367-4374 (1995).
43. Auwerx, J., and P. Sassone-Corsi. Factors modulating AP-1 activity, in The FOS and JUN Families of Transcription Factors (P. E. Angel and P. A. Herrlich, eds.). CRC Press, Boca Raton, 41-48 (1994).
44. 5 reductase. Cancer Res. 53:4907-4912 (1993).